sodium phenylbutyrate
NDC 68462-853, sodium phenylbutyrate, tablet, from GLENMARK PHARMACEUTICALS INC., USA.
- Product NDC
- 68462-853
- Status
- Listed
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216462
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-853 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM PHENYLBUTYRATE500 mg/1
Pharmacologic classes
Ammonium Ion Binding Activity [MoA]; Nitrogen Binding Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-853-20 | 68462085320 | 250 TABLET in 1 BOTTLE (68462-853-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0c76d25b-abac-41a3-a547-4fa4796bf7a4
Use it
Look up 68462-853 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-853 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-853. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.